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Backgrund/aims: Mycobacterium tuberculosis is still a major health problem throughout the world, especially in developing countries.
Disease control heavily depends on the establishment of early diagnosis. The aim of this study is to compare the efficacy of culture,
GeneXpert MTB/RIF device, and Erlich–Ziehl–Neelsen direct microscopic method.
Materials and methods: A total of 927 samples (243 respiratory and 684 nonrespiratory), which were sent to Ondokuz Mayıs University
Medical Faculty Tuberculosis Laboratory on suspicion of M. tuberculosis, were included in the study.
Results: When compared to standard culture, sensitivity, specificity, and positive and negative predictive values of the GeneXpert system
for respiratory samples were 100%, 98.7%, 87%, and 100%, respectively; these values for nonrespiratory samples were 71%, 98.6%, 71%,
and 98.6%, respectively.
Conclusion: New, reliable, rapid, and easy-to-use methods that display high specificity and sensitivity are required for an effective
struggle against tuberculosis. According to these results, we suggest that GeneXpert MTB/RIF is a rapid and reliable system, and when
used in company with conventional tests, it would make significant contributions to the diagnosis of tuberculosis.
Key words: Mycobacterium tuberculosis, GeneXpert MTB/RIF, culture

1. Introduction
Due to reasons such as health policies not giving due
importance to tuberculosis, demographic changes,
the human immunodeficiency virus epidemic, and
deteriorating socioeconomic conditions, Mycobacterium
tuberculosis is still a major health problem throughout the
world, especially in developing countries (1,2).
Despite having a variety of methods used in the
diagnosis of M. tuberculosis, culture (Lowenstein–Jensen
[LJ]) is still the gold standard (3). For a positive result,
10–100 bacilli/mL is sufficient (4,5). However, a period of
4 to 8 weeks is required for the colonies to be visible (6).
Erlich–Ziehl–Neelsen (EZN) staining, another method
used for the diagnosis of tuberculosis, is an indispensable
method due to its ease of application, low cost, and ability
to provide rapid results. However, factors such as the
staining method used, the experience of the evaluator,
the evaluation period for each sample, and the number
of samples evaluated for each patient affect the sensitivity
* Correspondence: kemal.bilgin@omu.edu.tr

of the method (5). In addition, in order to detect bacilli
in stained preparations, there should be approximately
5000–10,000 bacilli/mL. Therefore, negative microscopy
does not exclude the presence tuberculosis (4).
Early diagnosis of the disease and regular monitoring
of the treatment are important for an effective struggle
against the disease (1,6). The main disadvantages are as
follows: attainment of culture results takes a long time, and
direct microscopic examination has a low sensitivity (4,5).
Therefore, rapid, easy-to-use, and cost-effective laboratory
methods that provide high sensitivity and specificity are
required. For this purpose, nucleic acid amplification
(NAA)-based methods that can identify M. tuberculosis
through patient samples have been developed (7,8).
The aim of this study is to retrospectively compare
the results of culture (LJ and MGIT 960), the GeneXpert
MTB/RIF device (one of the polymerase chain reactionbased rapid diagnostic methods) (CEPHEID, USA), and
the direct microscopic method of EZN.
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2. Materials and methods
A total of 927 samples (243 respiratory samples from
sputum, bronchoalveolar lavage, and tracheal aspirate
and 684 nonrespiratory samples from urine, pleural
fluid, aspirate, cerebrospinal fluid [CSF], etc.) sent to the
Ondokuz Mayıs University Medical Faculty Tuberculosis
Laboratory between October 2011 and February 2014 on
suspicion of Mycobacterium tuberculosis were included in
the study.
After the decontamination process, a concentration
of 200 µL of each sample, except for CSF, was taken and
cultivated into LJ medium in a 0.5-mL MGIT tube and
incubated. Preparations were arranged from the same
sample for EZN staining and examined under a light
microscope at 100× magnification (5).
In addition, all samples were studied with the
GeneXpert system in accordance with the manufacturer’s
recommendations. For this purpose, decontaminated
samples were diluted with a sample reagent solution in the
ratio of 1:3 and were kept at room temperature for 15 min.
In accordance with aseptic technique, 2 mL of the mixture
was poured into the test cartridges and capped. The test
cartridge was then inserted into the GeneXpert device and
studied. The results were evaluated at the end of 2 h.
The specificity, sensitivity, and positive and negative
predictive values were used for the evaluation of the
performance of GeneXpert. SPSS 20.0 (IBM Corp., USA)
were used for the statistical analyses.
3. Results
Of the 243 respiratory samples, 177 were sputum, 64 were
bronchoalveolar lavage, and 2 were tracheal aspirate. Of
the 684 nonrespiratory samples, 171 were urine, 140 were
gastric fluid, 77 were pleural fluid, 63 were peritoneal fluid,
57 were surgical material, 50 were CSF, 47 were exudate,
45 were pericardial effusion, and 34 were other materials.
EZN, culture, and GeneXpert system positivity of the
927 samples were 2.7% (n = 25), 5.5% (n = 51), and 5.8%

(n = 54), respectively. While culture results were positive
for 9 nonrespiratory samples, the GeneXpert system and
EZN test results were negative. Although 12 samples (3
respiratory samples and 9 nonrespiratory samples) had a
negative culture result, the GeneXpert system was positive
for these samples. Of these 12 samples, EZN test results
found that 9 of the samples were negative, whereas 3
were identified as EZN-positive. Comparative results of 3
different tests are shown in Table 1.
When compared with culture results, the sensitivity,
specificity, positive predictive value (PPV), and negative
predictive value (NPV) of the GeneXpert system for
respiratory samples were 100%, 98.7%, 87%, and 100%,
respectively. These values for nonrespiratory samples were
71%, 98.6%, 71%, and 98.6%, respectively.
Comparison of EZN staining with culture results
revealed sensitivity of 60%, specificity of 100%, PPV of
100%, and NPV of 96.5% for respiratory samples; these
values for nonrespiratory samples were 32.3%, 99.5%,
76.9%, and 96.9%, respectively. The comparative results of
EZN and GeneXpert with culture are shown in Table 2.
4. Discussion
The need for rapid and reliable methods for the
diagnosis of tuberculosis has led to molecular diagnostic
methods becoming widespread and taking a strong and
complementary role along with conventional tests (9).
In the GeneXpert MTB/RIF system, M. tuberculosis
complex and rifampin resistance can be determined in
a single test in a short time (less than 2 h) directly from
patient material via a semiquantitative nested real-time
PCR method. Since all reagents required for the test are
kept in a closed cartridge, there is no cross-contamination
possibility between samples (10). It was reported that
NAA testing alone is not sufficient for the rapid diagnosis
of tuberculosis from suspicious clinical samples in routine
practice and that these test should not be used for screening
purposes. However, along with conventional tests, they

Table 1. Comparison of the GeneXpert system and EZN results with the results of culture.
TBC culture
Respiratory samples
(n = 243 [26.2%])

EZN
GeneXpert PCR
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Nonrespiratory samples
(n = 684 [73.8%])

Positive
(n = 20)

Negative
(n = 223)

Positive
(n = 31)

Negative
(n = 653)

Positive

12

0

10

3

Negative

8

223

21

650

Positive

20

3

22

9

Negative

0

220

9

644
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Table 2. Sensitivity, specificity, PPV, and NPV in comparison of GeneXpert system and EZN with culture.

Respiratory samples
Nonrespiratory samples

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

EZN

60

100

100

96.5

GeneXpert

100

98.7

87

100

EZN

32.3

99.5

76.9

96.9

GeneXpert

71

98.6

71

98.6

are considered to be quite valuable in supporting clinical
findings (9).
In the study by Bunsow et al., sensitivity, specificity,
PPV, and NPV of the GeneXpert system for respiratory
samples and nonrespiratory samples were found to be
97.1%, 98.6%, 95.7%, and 99.1% and 33.3%, 99.7%,
80.0%, and 97.3% respectively. The GeneXpert system was
reported to be a rapid and easy-to-use test giving accurate
results in identifying M. tuberculosis, particularly in smearpositive respiratory samples (11).
In their study of 521 nonrespiratory samples, Hillemann
et al. compared the results of the GeneXpert system with
those of conventional liquid (MGIT 960) and solid (LJ)
culture methods and found sensitivity and specificity as
77.3% and 98.2%, respectively. They expressed that the
GeneXpert system is a rapid and useful technique in the
identification of nonrespiratory tuberculosis (12).
Ioannidis et al. compared the results of culture methods
(LJ and MGIT 960) with those of the GeneXpert system
and found sensitivity, specificity, PPV, and NPV as 90.6%,
94.3%, 93.5%, and 91.7% in respiratory samples and
100%, 91.6%, 50%, and 100% in nonrespiratory samples,
respectively. At the end of the study, they concluded that
the GeneXpert system, a NAA-based method, would be
beneficial in treating tuberculosis (13).
In a study conducted in Turkey, Çiftçi et al. compared
the performance of the Xpert MTB/RIF system with
those of the BACTEC 460TB 12B (BD Diagnostic, USA),
the LJ culture, and the Ziehl–Neelsen direct microscopic
examination method. When BACTEC 460TB results were
taken as the reference, the sensitivity, specificity, PPV, and
NPV of the Xpert MTB/RIF system were found to be 96%,
98%, 96%, and 98%, respectively (14).

In their study, Özkütük et al. compared Xpert MTB/
RIF test results with culture results (BACTEC MGIT 960
and LJ medium). For pulmonary samples, specificity,
sensitivity, PPV, and NPV were found to be 80.8%,
98.8%, 84.9%, and 98.4%, respectively. These values for
nonpulmonary samples were 58.2%, 98.4%, 66.7%, and
97.7%, respectively. They suggested that Xpert MTB/RIF
is a useful method for the diagnosis of tuberculosis (15).
In our study, we had 9 false negative results from
the GeneXpert system; all were nonrespiratory tract
samples. There were twelve false positive results; 3 were
respiratory samples and 9 were nonrespiratory samples.
It was understood that 100% of false negative and 75% of
false positive results occurred in nonrespiratory samples.
Since live and dead bacilli cannot be distinguished by PCR
methods, it is known that false positivity can be seen in
patients with a history of tuberculosis (5).
In accordance with our results obtained from the
comparison of the GeneXpert system, EZN staining, and
culture in terms of sensitivity, specificity, PPV, and NPV,
we found that the literature shows that the GeneXpert
system has higher sensitivity rates for both respiratory and
nonrespiratory samples and that these results were similar
with respect to other values.
In conclusion, early diagnosis is of great importance
for the treatment of tuberculosis. For this purpose, easyto-use new methods that can provide reliable and fast
results with high specificity and sensitivity are being
sought. According to these results, we can conclude that
the GeneXpert MTB/RIF is a rapid and reliable system
that can be employed in the diagnosis of tuberculosis, and
when utilized together with conventional tests, it can make
significant contributions to tuberculosis diagnosis.
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